4448190
doi
10.5281/zenodo.4448190
oai:zenodo.org:4448190
THE PREVALENCE OF DEPRESSION AMONG CANCER PATIENTS FROM PRINCESS NOORAH ONCOLOGY CENTER AT JEDDAH
Dr. Hatim Al-jifree (PI), Dr. Mohammed Bafail, Dr. Oday Qurashi, Dr. Anmar alkindy, Dr. Mohammed Bajunaid, Dr. Hala Zahed, 5Dr. Yara Mickael
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
<p><strong><em>Background:</em></strong><em> Cancer is a fatal disease in Saudi Arabia. According to WHO, </em><em>“</em><em>Cancers are the leading causes of mortality, with approximately 14 million new cases and 8.2 million cancer-related mortalities in 2012.</em><em>” </em><em>Additionally, about 25% of cancer patients experience depression.</em></p>
<p><em>This study aims to estimate the prevalence of depression among cancer patients. Our study is a cross-sectional study and was conducted at Princess Noorah Oncology Center in King Abdulaziz Medical City, Jeddah.</em></p>
<p><strong><em>Subjects and Methods: </em></strong><em>We studied patients (</em><em>≥ </em><em>18 years old) in both genders with confirmed cancer diagnosis regardless of treatment initiation and who were aware of their diagnosis. The study consisted of 281 patients.</em></p>
<p><strong><em>Results:</em></strong><em> Most patients were female (55.5%). For patients by age groups, 112 patients (39.9%) were at age group of 40 to 59, 91 patients (32.4%) were at </em><em>≥ </em><em>60 years old, 62 patients (22.1%) aged 20 to 39 and 16 patients (5.7%) aged < 20 years old. The most important factor causing depression among cancer patients was the number of chemotherapy cycles (p-value = 0.012). Additionally, based on the analysis of Patient Health Questionnaire-9 (PHQ9) scores, only 95 patients (33.8%) had no depression, while the rest suffered from varying degrees of depression. Mild depression 112 patients (39.9%)] was the most common among patients with depression.</em></p>
<p><strong><em>Conclusion:</em></strong><em> Early detection of depression is essential to enhance compliance and prognosis. However, further research is necessary to develop a standardized approach to mitigate depression among cancer patients.</em></p>
<p><strong><em>Key words:</em></strong><em> </em><em>Saudi Arabia, Depression, Cancer, PHQ9.</em></p>
Zenodo
2021-01-18
info:eu-repo/semantics/article
4448189
1611016037.477956
3004762
md5:860b7fbe6812cd6abf67d5f028d7a7be
https://zenodo.org/records/4448190/files/396.IAJPS-HALZAW.pdf
public
10.5281/zenodo.4448189
isVersionOf
doi